- Home
- BTAI vs MDBH Comparison
BTAI vs MDBH Comparison
Compare BTAI & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTAI | MDBH |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 36.7M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BTAI | MDBH |
|---|---|---|
| Price | $1.07 | $3.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 6.8K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $197.82 | N/A |
| Revenue Next Year | $910.15 | N/A |
| P/E Ratio | ★ N/A | $4.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $2.75 |
| 52 Week High | $8.08 | $5.50 |
Technical Indicators
Market Signals| Indicator | BTAI | MDBH |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 63.76 |
| Support Level | N/A | $3.16 |
| Resistance Level | $1.26 | $3.80 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 24.49 | 65.35 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.